CURE PHARMACEUTICAL HOLDING CORP.

Profile

Company Names

CURE PHARMACEUTICAL HOLDING CORP.

Addresses

1620 BEACON PLACE, OXNARD, CA 93033

Phone Numbers

805-824-0410

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

NEVADA

Total Amount Raised:

$31,538,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-10-30 
$11,500,000.00 
$11,500,000.00 
$0.00 
Debt 
2
2019-05-14 
$19,038,000.00 
$19,038,000.00 
$0.00 
Equity 
1
2018-03-20 
$1,000,000.00 
$5,000,000.00 
$4,000,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
BELL 
DIRECTOR
JENNEREX, INC.   |  SOURCE ROCK ROYALTIES LTD.   |  CULTIVATE MUSIC, INC.   |  GESTALT DIAGNOSTICS, LLC   |  CURE PHARMACEUTICAL HOLDING CORP.   |  PRIMETIME HOLDINGS INC.   |  IMMUNOCORE HOLDINGS PLC   |  NEVIS BRANDS INC.   |  TAMBORAN RESOURCES CORP
CHARLES 
 
BERMAN 
DIRECTOR
GROWER-S SECRET, INC.   |  CURE PHARMACEUTICAL HOLDING CORP.   |  FOGCHAIN CORP.
LAUREN 
 
CHUNG 
DIRECTOR
CURE PHARMACEUTICAL HOLDING CORP.   |  FOOTURA INC.
ROBERT 
 
DAVIDSON 
DIRECTOR, EXECUTIVE OFFICER
BROADWAY FINANCIAL CORP \DE\   |  CURE PHARMACEUTICAL CORP   |  CURE PHARMACEUTICAL HOLDING CORP.   |  NEW WAY HOMES, INC.   |  GATC HEALTH CORP
NANCY 
 
DUITCH 
DIRECTOR
CURE PHARMACEUTICAL HOLDING CORP.
ALAN 
 
EINSTEIN 
DIRECTOR
CURE PHARMACEUTICAL HOLDING CORP.
ANYA 
 
GOLDIN 
DIRECTOR
PETROTEQ ENERGY INC.   |  CURE PHARMACEUTICAL HOLDING CORP.
JOSH 
 
HELD 
DIRECTOR
CURE PHARMACEUTICAL HOLDING CORP.   |  FIRST RESPONDER HOLDING CO
ALEX 
 
KATZ 
EXECUTIVE OFFICER
FF SAPPHIRE (IV) VENTURE CAPITAL FUND, LP   |  LOVE WILL INC.   |  FF GRAPHITE (V) VENTURE CAPITAL FUND, L.P.   |  DIFFERENTIAL VENTURE CAPITAL FUND I, LP   |  CURE PHARMACEUTICAL HOLDING CORP.   |  PACIFIC PSYCHOTHERAPY TECHNOLOGIES, INC.   |  CLOSING DOCS, INC.   |  PHONEMIX LTD
RUBEN 
 
KING-SHAW 
DIRECTOR
CURE PHARMACEUTICAL HOLDING CORP.
EDWARD 
 
MALISKI 
EXECUTIVE OFFICER
CURE PHARMACEUTICAL CORP   |  CURE PHARMACEUTICAL HOLDING CORP.
MIKE 
 
REDARD 
EXECUTIVE OFFICER
CURE PHARMACEUTICAL HOLDING CORP.
JESSICA 
 
ROUSSET 
EXECUTIVE OFFICER
CURE PHARMACEUTICAL HOLDING CORP.
GENE 
 
SALKIND 
DIRECTOR
MOBIQUITY TECHNOLOGIES, INC.   |  DERMTECH, INC.   |  CURE PHARMACEUTICAL HOLDING CORP.   |  GROVE, INC.   |  COEPTIS THERAPEUTICS HOLDINGS, INC.   |  ADAPTIIV MEDICAL TECHNOLOGIES INC.   |  UPEXI, INC.
MARK 
 
UDELL 
EXECUTIVE OFFICER
CURE PHARMACEUTICAL CORP   |  CURE PHARMACEUTICAL HOLDING CORP.
WILLIAM 
 
YUAN 
DIRECTOR
AMERICAN NATURAL ENERGY CORP   |  CURE PHARMACEUTICAL HOLDING CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-11-13
D
Link
PHARMACEUTICALS 
PLASTICS, FOIL + COATED PAPER BAGS [2673] 
DECLINE TO DISCLOSE 
Debt 
2020-10-30 
2019-05-29
D
Link
PHARMACEUTICALS 
PLASTICS, FOIL + COATED PAPER BAGS [2673] 
$1 - $1,000,000 
Equity 
2019-05-14 
2019-05-29
D/A
Link
PHARMACEUTICALS 
PLASTICS, FOIL + COATED PAPER BAGS [2673] 
$1 - $1,000,000 
Equity 
2019-05-14 
2018-04-05
D
Link
PHARMACEUTICALS 
PLASTICS, FOIL + COATED PAPER BAGS [2673] 
$1 - $1,000,000 
 
2018-03-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
AXIOM CAPITAL MANAGEMENT, INC.
265801
NONE
NONE
NONE
NONE
NONE
NONE
ALEXANDER CAPITAL, L.P.
40077